Literature DB >> 18467159

Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure.

Pascal Pineau1, Agnès Marchio, Carlo Battiston, Emilie Cordina, Alessandro Russo, Benoît Terris, Lun-Xiu Qin, Bruno Turlin, Zhao-You Tang, Vincenzo Mazzaferro, Anne Dejean.   

Abstract

Hepatocellular carcinoma (HCC) is a heterogeneous disease triggered by various risk factors and frequently characterized by chromosome instability. This instability is considered to be caused primarily by Hepatitis B virus (HBV), although aflatoxin B1 (AFB1), a potent fungal mutagen is also suspected to influence chromosomal repair. We studied 90 HCCs from Italy, the country with the highest incidence of hepatocellular carcinoma in Europe, 81 samples from France and 52 specimens from Shanghai, in a region where intake of AFB1 via the diet is known to be high. All 223 tumours were characterized for 15 different genomic targets, including allelic loss at 13 chromosome arms and mutations of beta-catenin and p53 genes. Despite disparity in risk-factor distribution, Italian and French cases did not significantly differ for 14 of the 15 targets tested. beta-Catenin and p53 displayed moderate and similar mutation rates (18-29% of cases) in European series. By contrast, tumours from Shanghai were significantly different, with a lower mutation rate for beta-catenin (4% vs. 26%, p<0.0003) and a higher mutation rate for p53 (48% vs. 22%, p<0.0001) when compared with tumours of European origin. The Arg249Ser mutation, hallmark of exposure to AFB1, represented half of the changes in p53 in Shanghai. Furthermore, when stratified for the presence of HBV or p53 mutations, chromosome instability was always higher in Chinese than in European patients. This difference was particularly strong in p53-wildtype tumours (fractional allelic loss, 29.4% vs. 16.7%, p<0.0001). We suggest that AFB1-associated mutagenesis represents a plausible cause for the higher chromosome instability observed in Chinese HCCs, when compared with European primary liver carcinomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467159     DOI: 10.1016/j.mrgentox.2008.01.012

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  22 in total

1.  Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.

Authors:  Jin-Guang Yao; Xiao-Ying Huang; Xi-Dai Long
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 2.  Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.

Authors:  Tamara Severi; Hannah van Malenstein; Chris Verslype; Jos F van Pelt
Journal:  Acta Pharmacol Sin       Date:  2010-10-18       Impact factor: 6.150

3.  New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.

Authors:  Kevin David Shield; Claire Marant Micallef; Catherine de Martel; Isabelle Heard; Francis Megraud; Martyn Plummer; Jérôme Vignat; Freddie Bray; Isabelle Soerjomataram
Journal:  Eur J Epidemiol       Date:  2017-12-06       Impact factor: 8.082

4.  miR-221 overexpression contributes to liver tumorigenesis.

Authors:  Pascal Pineau; Stefano Volinia; Katherine McJunkin; Agnès Marchio; Carlo Battiston; Benoît Terris; Vincenzo Mazzaferro; Scott W Lowe; Carlo M Croce; Anne Dejean
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

5.  Aflatoxin B(1)-Associated DNA Adducts Stall S Phase and Stimulate Rad51 foci in Saccharomyces cerevisiae.

Authors:  Michael Fasullo; Yifan Chen; William Bortcosh; Minzeng Sun; Patricia A Egner
Journal:  J Nucleic Acids       Date:  2010-12-02

6.  Mycotoxins and human disease: a largely ignored global health issue.

Authors:  Christopher P Wild; Yun Yun Gong
Journal:  Carcinogenesis       Date:  2009-10-29       Impact factor: 4.944

7.  Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome.

Authors:  Anna-Maria Tanase; Agnès Marchio; Traian Dumitrascu; Simona Dima; Vlad Herlea; Gabriela Oprisan; Anne Dejean; Irinel Popescu; Pascal Pineau
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-04-16       Impact factor: 5.563

8.  Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma.

Authors:  Wen-Jing Lu; Mei-Sze Chua; Samuel K So
Journal:  Carcinogenesis       Date:  2013-12-03       Impact factor: 4.944

9.  Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.

Authors:  Agnès Marchio; Marie Amougou Atsama; Aubin Béré; Narcisse-Patrice Komas; Dominique Noah Noah; Paul Jean Adrien Atangana; Serge-Magloire Camengo-Police; Richard Njouom; Claudine Bekondi; Pascal Pineau
Journal:  Clin Exp Med       Date:  2018-05-10       Impact factor: 3.984

10.  Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma.

Authors:  Ling Xiao Liu; Nikki P Lee; Vivian W Chan; Wen Xue; Lars Zender; Chunsheng Zhang; Mao Mao; Hongyue Dai; Xiao Lin Wang; Michelle Z Xu; Terence K Lee; Irene O Ng; Yangchao Chen; Hsiang-fu Kung; Scott W Lowe; Ronnie T P Poon; Jian Hua Wang; John M Luk
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.